Status:
NOT_YET_RECRUITING
Clinical and Radiographic Success of Pulpotomy Using Neoputty Mineral Trioxide Aggregate Versus Pulpectomy Using Endoflas In Primary Molars With Irreversible Pulpitis: A Randomized Controlled Trial
Lead Sponsor:
Cairo University
Conditions:
Pulpitis - Irreversible
Eligibility:
All Genders
4-9 years
Phase:
NA
Brief Summary
The goal of this randomized clinical trial is to evaluate the clinical and radiographic success of pulpotomy using Neoputty MTA vital primary molars diagnosed with symptomatic irreversible pulpitis. ...
Eligibility Criteria
Inclusion
- Children with spontaneous pain lasting a few seconds to several hours.
- Pain is intensified by thermal stimulus and persists after its removal.
- Pulp hemorrhage after performing access cavity and deroofing of pulp chamber showing reddish pink healthy pulp tissue.
- Radicular pulp health is verified by achieving hemostasis within six minutes of compression using a cotton pellet with 2% sodium hypochlorite.
- Absence of peri-apical or inter-radicular radiolucency, widening of periodontal ligament space, internal or external root resorption.
Exclusion
- Unrestorable primary molars.
- Primary molars with uncontrolled pulp hemorrhage or pulp necrosis.
- Medically compromised patients who have systemic disease.
- Uncooperative children who refuse treatment.
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT06922578
Start Date
May 1 2025
End Date
June 1 2026
Last Update
April 10 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.